Skip to content
RDL Network logo
Two-year follow-up of the RAVEL study: A randomized study with the sirolimus-eluting Bx VELOCITY stent in the treatment of patients with denovo native coronary artery lesions — Marie‐Claude Morice (2003) | RDL Network